STOCK TITAN

Augmedix to Report 2021 Third Quarter Financial Results on November 9, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Augmedix, Inc. (Nasdaq: AUGX) will report its financial results for Q3 2021 on November 9, 2021, after market close. The company specializes in virtual medical documentation and clinical support, aiming to enhance healthcare efficiency. Augmedix's platform converts physician-patient conversations into accurate medical notes, significantly reducing the time doctors spend on paperwork. This allows physicians to save 2-3 hours daily, boost productivity by up to 20%, and improve work-life satisfaction by over 40%. A conference call will follow the release.

Positive
  • Augmedix's platform saves physicians 2-3 hours daily.
  • Productivity improvement of up to 20%.
  • Over 40% increase in physician satisfaction with work-life balance.
Negative
  • None.

SAN FRANCISCO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced it will report financial results for the third quarter 2021 on Tuesday, November 9, 2021, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Conference Call & Webcast Details
The conference call can be accessed by dialing +1 (877) 407-3982 for U.S. participants or +1 (201) 493-6780 for international participants and referencing conference ID #13723538. Interested parties may access a live and archived webcast of the event on the “Investor Relations” section of the Company’s website at: https://ir.augmedix.com/.

About Augmedix

Augmedix, Inc. (Nasdaq: AUGX) is a leading digital health platform that offers virtual medical documentation and live clinical support to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments and telemedicine practices nationwide. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into accurate and comprehensive medical notes in a timely fashion and provides a suite of industry-leading ancillary services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automated speech recognition and natural language processing and is overseen by trained medical documentation specialists. Augmedix can save physicians 2–3 hours per day, improve productivity by as much as 20%, and increase satisfaction with work-life balance by over 40%. To learn more about Augmedix visit augmedix.com.

Investors:
Caroline Paul
Gilmartin Group
investors@augmedix.com

Media:
Kaila Grafeman
Augmedix
pr@augmedix.com


FAQ

When will Augmedix report its Q3 2021 financial results?

Augmedix will report its Q3 2021 financial results on November 9, 2021, after market close.

What services does Augmedix provide?

Augmedix offers virtual medical documentation and live clinical support to healthcare systems and physician practices.

How does Augmedix's platform benefit physicians?

The platform converts physician-patient conversations into comprehensive medical notes, saving time and improving productivity.

What time is the Augmedix Q3 2021 conference call?

The conference call will occur at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on November 9, 2021.

How can I access the Augmedix conference call?

You can access the conference call by dialing +1 (877) 407-3982 for U.S. participants or +1 (201) 493-6780 for international participants.

Augmedix, Inc.

NASDAQ:AUGX

AUGX Rankings

AUGX Latest News

AUGX Stock Data

116.16M
48.69M
1.5%
84.78%
2.16%
Health Information Services
Services-business Services, Nec
Link
United States of America
SAN FRANCISCO